Research and experimental development on natural sciences and engineering
BIOMOLEX AS
Revenue 2024
NOK 301,000
Operating profit
NOK −401,000
Equity
NOK −245,000
Incorporated
2001
Share capital
NOK 832,000
Key figures · 2024
Current ratio
0.00
Equity ratio
-25462.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -133.4% | |
| Net margin (%%) | -133.4% | |
| Return on assets (%%) | -41775.3% | |
| Likviditet | ||
| Current ratio | 0.00 | |
| Working capital | −245k | |
| Soliditet | ||
| Equity ratio (%%) | -25462.7% | |
| Debt-to-equity ratio | -1.00 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.